Description

Gluvilda-M Vildagliptin Metformin 500mg: An Overview

Gluvilda-M  500mg combines two antidiabetic agents, Vildagliptin and Metformin Hydrochloride, to manage blood sugar levels in individuals with type 2 diabetes. Specifically, Vildagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels. Meanwhile, Metformin lowers hepatic glucose production and improves insulin sensitivity. Consequently, these complementary mechanisms provide better glycemic control.

Usage and Administration

Doctors prescribe this oral tablet when single-agent therapy does not adequately control glucose. Patients should take it with food to minimize gastrointestinal side effects. Furthermore, patients must follow a consistent diet and exercise plan for optimal outcomes. However, it is not suitable for individuals with type 1 diabetes or those experiencing diabetic ketoacidosis.

Manufacturing and Safety

Alkem Laboratories Ltd. manufactures Gluvilda-M Vildagliptin Metformin 500mg. Generally, patients tolerate this formulation well. Nevertheless, doctors should monitor patients for gastrointestinal symptoms and rare risks, such as lactic acidosis, particularly in cases of renal impairment

Availability and Purchase of Gluvilda-M Vildagliptin Metformin 500mg

Genetec Lifesciences makes Gluvilda-M 500mg available. To place an order or request a quote, contact us directly. We ensure that we source all products from verified and authorized vendors.

Disclaimer

Product information mentioned on this site is for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.